361 related articles for article (PubMed ID: 21732474)
1. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
[TBL] [Abstract][Full Text] [Related]
2. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.
Prigione A; Fauler B; Lurz R; Lehrach H; Adjaye J
Stem Cells; 2010 Apr; 28(4):721-33. PubMed ID: 20201066
[TBL] [Abstract][Full Text] [Related]
3. Somatic cells with a heavy mitochondrial DNA mutational load render induced pluripotent stem cells with distinct differentiation defects.
Wahlestedt M; Ameur A; Moraghebi R; Norddahl GL; Sten G; Woods NB; Bryder D
Stem Cells; 2014 May; 32(5):1173-82. PubMed ID: 24446123
[TBL] [Abstract][Full Text] [Related]
4. Heteroplasmic mutation of mitochondrial DNA D-loop and 4977-bp deletion in human cancer cells during mitochondrial DNA depletion.
Lee HC; Hsu LS; Yin PH; Lee LM; Chi CW
Mitochondrion; 2007; 7(1-2):157-63. PubMed ID: 17280876
[TBL] [Abstract][Full Text] [Related]
5. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
6. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells.
Ji J; Ng SH; Sharma V; Neculai D; Hussein S; Sam M; Trinh Q; Church GM; McPherson JD; Nagy A; Batada NN
Stem Cells; 2012 Mar; 30(3):435-40. PubMed ID: 22162363
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells' self-renewal and pluripotency is maintained by a bovine granulosa cell line-conditioned medium.
Solari C; Losino N; Luzzani C; Waisman A; Bluguermann C; Questa M; Sevlever G; Miriuka S; Barañao L; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(2):252-7. PubMed ID: 21651896
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs.
Kang E; Wang X; Tippner-Hedges R; Ma H; Folmes CD; Gutierrez NM; Lee Y; Van Dyken C; Ahmed R; Li Y; Koski A; Hayama T; Luo S; Harding CO; Amato P; Jensen J; Battaglia D; Lee D; Wu D; Terzic A; Wolf DP; Huang T; Mitalipov S
Cell Stem Cell; 2016 May; 18(5):625-36. PubMed ID: 27151456
[TBL] [Abstract][Full Text] [Related]
10. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
11. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
12. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
14. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging.
Wei YH; Wu SB; Ma YS; Lee HC
Chang Gung Med J; 2009; 32(2):113-32. PubMed ID: 19403001
[TBL] [Abstract][Full Text] [Related]
15. Surveyor Nuclease: a new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects.
Bannwarth S; Procaccio V; Paquis-Flucklinger V
Hum Mutat; 2005 Jun; 25(6):575-82. PubMed ID: 15880407
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming.
Yokota M; Hatakeyama H; Okabe S; Ono Y; Goto Y
Hum Mol Genet; 2015 Aug; 24(16):4698-709. PubMed ID: 26025377
[TBL] [Abstract][Full Text] [Related]
18. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
19. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cell-derived models for mtDNA diseases.
Hämäläinen RH
Methods Enzymol; 2014; 547():399-415. PubMed ID: 25416367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
